Pfizer (PFE)
$40.56
0.05 (0.12%)
PFE Stock Quote Delayed 15 Minutes
Previous Close
$40.61
Market Cap
237.26B
PE Ratio
11.27
EPS
3.6
Volume (Avg. Vol.)
6.28M
Day's Range
40.50 - 40.81
52-Week Range
33.97 - 44.56
Dividend & Yield
1.36 (3.35%)
PFE Stock Predictions, Articles, and Pfizer News
Pfizer Stock Offers Good Value to Patient Investors
Pfizer stock offers good value to patient investors. Pfizer's new spinoffs will provide a higher total return to the owners of Pfizer stock.
3 Big Stock Charts for Tuesday: Pfizer, Clorox, and L Brands
Tuesday's big stock charts focus on 3 value plays that are looking to continue recent breakouts.
Dow Jones Today: Stocks Pinched by Jobs Disappointment
The December jobs report was't as strong as economists expected and that triggered some modest selling on Wall Street to close the week.
Pfizer Stock Has No Momentum in Its Business or on the Charts
Pfizer stock has no momentum right now. Earnings and revenue are in decline and the charts are struggling. I would avoid for now.
A Recent FDA Approval Will Be Huge in Moving Amarin Stock
FDA approval of Vascepa in use for cardiovascular events just widened Amarin’s revenue potential. Amarin stock should have a banner 2020.
5 Top Stock Trades for Wednesday: MU, SQ, WMT
Walmart, Micron, Square, Beyond Meat and Pfizer were our top stock trades for Wednesday. Let's look at the charts.
After Lackluster 2019, Pfizer Stock Could Rebound in 2020
Wall Street has discounted Pfizer's divestiture plans. But spinning off off-patent drugs could improve the valuation of PFE stock.
Dow Jones Today: Trade Progress Pushes Stocks, Healthcare Helps Dow
The lagging healthcare sector has been building momentum and that boosted the Dow Jones Industrial Average today.
3 Big Stock Charts for Friday: Snap, Pfizer and Splunk
Friday's 3 big stock charts highlight 3 names looking for help from a market at all-time highs.
Should Investors Buy Pfizer Stock Before Next Year’s Huge Shake Up?
There's a strong case for investing in Pfizer stock. With a great deal of uncertainty in the near-term, however, some patience with PFE stock may be required.
Why This Just Might Be the Biggest Week for CARA Stock
Cara stock is up ahead of its presentations at Kidney Week 2019. Unless it reports bad news, Cara Therapeutics looks ready to run.
Stock Market Today: Earnings, Fed Drive New Highs
The S&P 500 hit another new all-time high on Tuesday. Here's what happened in the stock market today to get it there.
5 Top Stock Trades for Wednesday: GM, AAPL, SHOP, GRUB, PFE
GrubHub, Shopify, Apple, Pfizer and General Motors were our top stock trades from Tuesday. Here's a look at the charts.
Tuesday’s Vital Data: Fitbit, Pfizer and Twitter
Options trading was hot in Fitbit, Pfizer, and Twitter on Monday. Here’s what the data suggests moving forward.
Akcea Therapeutics News: AKCA Stock Rockets on Pfizer Licensing Deal
Akcea Therapeutics (AKCA) stock is flying high on Monday following news of a $250 million deal with Pfizer (NYSE:PFE) for licensing rights.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
D
